학술논문

Feasibility and Outcome of Post-Induction Therapy Incorporating Dasatinib for Patients with Newly Diagnosed ABL-Class Fusion B- Lymphoblastic Leukemia (ABL-class Fusion BALL): Children's Oncology Group AALL1131